NSE Symbol

ACUTAAS

In accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of Acutaas Chemicals Limited held a meeting on Friday, July 24, 2026.

The Board meeting commenced at 11:00 a.m. and concluded later the same day.

The primary outcome of the meeting was the consideration and approval of the company's Unaudited Standalone and Consolidated Financial Results for the first quarter ended June 30, 2026.

These financial results were previously reviewed and recommended by the company's Audit Committee. The Statutory Auditors of the company, M/s Maheshwari & Co., Chartered Accountants, issued a Limited Review Report on these financial results.

The disclosure was signed by Ekta Kumari Srivastava, Company Secretary & Compliance Officer, on behalf of Acutaas Chemicals Limited.